N/A (device / behavioral)RecruitingNCT06739811

Medtronic implantable insulin pump system (MIIPS 2020)

What this study tests

Clinical evaluation of Medtronic implantable insulin pump technology in adults with T1D, a rare long-horizon delivery-device pathway.

Editorial review: 2026-09-16.

Registry checked: 2026-09-17. Registry’s own update: 2026-08-06.

Source dates appear in the references where available; this record has no dated citation metadata.

Trial status, labels and access can change between reviews. How we review the evidence · How to read the evidence

Full sources ↓Full discussion ↓Report an issue →

Evidence at a glance

Who can enter the study?: Adults with T1D for at least six months and frequent unexplained severe high or low glucose despite subcutaneous insulin therapy, including an external pump. A reliable daily support person and ability to operate the implanted pump are required; see registry for full exclusions. Registered eligibility ↗Enrollment criteria describe who may enter. They do not establish who was analyzed or the denominator for a reported result.
Reported benefit and results: No results posted yet.Read the result sources and their limitations →
Important harms: Read the reported results, safety discussion and original sources. A separate harms summary is not available; this does not establish safety.
Research access and approval: Study regions: European Union. A trial listing does not establish product approval or current recruitment at a particular site. Check the study’s current entry requirements.
What remains uncertain?: Read the full discussion and original sources for study limitations. Planned endpoints and completion dates are not results.

Research status alone does not establish approval, clinical benefit or local availability.

Primary endpoints

Refill accuracy of MIIPS 2020

The full picture

This record has no longer discussion. Use the study criteria, reported results and original sources on this page to assess what is known and what remains unresolved.

Sources

[1]
NCT06739811: Medtronic implantable insulin pump system (MIIPS 2020) · Trial registry